about
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesCrystal structure of the yeast nicotinamidase Pnc1pInhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidicIn vitro antimycobacterial activities of pyrazinamide analogsMolecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidaseCost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort StudyTreatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists.Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population.Adverse reactions to antituberculosis drugs in Iranian tuberculosis patients.Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.Metal-ion effects on the polarization of metal-bound water and infrared vibrational modes of the coordinated metal center of Mycobacterium tuberculosis pyrazinamidase via quantum mechanical calculations.Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis.Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosis.Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosisDetecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection.A guide to the management of tuberculosis in patients with chronic liver disease.Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended dosesAntituberculosis drug research: a critical overview.Recent progress on pyrazole scaffold-based antimycobacterial agents.Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide?Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in ChinaCharacterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) gene.Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.Evaluation of the teratogenic potential of pyrazinamide in Wistar rats.Heterogeneous behavior of metalloproteins toward metal ion binding and selectivity: insights from molecular dynamics studies.Toxicity associated with tuberculosis chemotherapy in the REMoxTB studyPhenotypic and genotypic drug sensitivity of complex isolated from South Omo Zone, Southern EthiopiaStructure of Type-I Mycobacterium tuberculosis fatty acid synthase at 3.3 Å resolutionPrimary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular
P2860
Q27004697-956089E5-0A27-4D93-A527-88D7EB31E370Q27644216-3A86212F-2ABB-4DCA-BD83-9A7094660487Q28329787-04A1FB68-6AAC-456B-AFDF-B1CD39D9B445Q28333302-D2AA0462-8E39-45AE-8623-1841DA57F5FDQ28378748-AB0C7C6B-B609-4D91-80DC-5F079859974FQ28480662-7D1ED36E-F311-4A80-962E-0907AE881DF4Q28547335-1B8F3029-B314-44EC-BEEA-31FF7521FCA8Q30383012-38C9B692-6237-4D24-99AA-355A103B915AQ33889576-51E10A84-13F1-4DE2-A265-CAAF1E3F3E18Q34524078-06D69F25-2882-47CF-B3AE-C9893994DAA1Q34660150-CDA67626-8340-4FAC-8B0C-CF14DCF6F75AQ34737913-6FA7A58B-B79E-4C04-ACC9-F74C5525C766Q35718261-F1E790D2-51E0-48FE-95BF-D574A26F5A67Q35779318-A9EFFF6C-A6EA-4B7F-AAF7-81B95EB7DF33Q35879089-1E14E207-BE26-42C7-99D4-913C75F8A308Q35886968-ACEA91EF-E7C2-4236-AFD1-9FC8284309A4Q36080072-D569B404-0D02-4D5A-AEE0-214FFA113212Q36291893-1509BAF0-FF97-4C16-9788-29A0EB84E9F3Q36364005-ABCB0BCD-7644-4BAF-8DB1-F595E47DE76FQ36613180-FBB8A56B-0EBC-46B0-ABC1-CEB307C117BAQ37127014-5F023BCF-893A-4E39-A155-BFD01A99D067Q37215691-D44C14C7-091D-49F4-8AF2-693BC2DCA626Q37499482-16785EF9-E1CC-4B59-8EDC-FE888CCD66B5Q37613934-85A2B9AD-0DB9-42D2-A903-67ACA3DF30BEQ37688266-ABEA6B52-9CD7-4C5B-B7E1-AD28CC5E2619Q38012651-E2F054C2-0779-4421-9195-86EAE4D4F977Q38395200-4F4DE6D9-118D-4EF5-B2A8-DA8325B8EDB3Q38542018-DF98E13F-16B4-4053-8FED-1BFA408E6375Q38718396-CFD61B99-7BAC-4DCC-A464-5CFD475AF1F6Q38729024-405BD852-5826-40CA-8456-37DAA543AE99Q39785436-9ED3B10B-03CB-41D5-B875-3639E066E417Q40909374-AC7992CA-B4A5-4EE6-9571-A5D77F0CA5ABQ42618592-2FF1E094-1302-43A5-A24C-F0321FB11B6DQ44555554-A2002FB0-EAF8-4022-B71C-BB242CBD93F9Q51819200-026D5239-7F21-4235-9BCA-6EBA9D704662Q56969466-9BFA9EB1-281A-4C0D-8E05-41D7FB6678EFQ57069790-B61A6C3D-04D4-4E6F-B70B-C9F500EED3B9Q58700404-2146E80F-98F7-4089-B81A-ED91DDAC6A94Q58729009-03327FBF-DCDB-4767-BCF5-965AE6B4538E
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The role of pyrazinamide in tuberculosis chemotherapy.
@en
The role of pyrazinamide in tuberculosis chemotherapy.
@nl
type
label
The role of pyrazinamide in tuberculosis chemotherapy.
@en
The role of pyrazinamide in tuberculosis chemotherapy.
@nl
prefLabel
The role of pyrazinamide in tuberculosis chemotherapy.
@en
The role of pyrazinamide in tuberculosis chemotherapy.
@nl
P356
P1433
P1476
The role of pyrazinamide in tuberculosis chemotherapy.
@en
P2093
Des Prez RM
P304
P356
10.1378/CHEST.94.4.845
P407
P577
1988-10-01T00:00:00Z